140 related articles for article (PubMed ID: 29090456)
1. Does HPV status influence survival after vulvar cancer?
Rasmussen CL; Sand FL; Hoffmann Frederiksen M; Kaae Andersen K; Kjaer SK
Int J Cancer; 2018 Mar; 142(6):1158-1165. PubMed ID: 29090456
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva.
Faber MT; Sand FL; Albieri V; Norrild B; Kjaer SK; Verdoodt F
Int J Cancer; 2017 Sep; 141(6):1161-1169. PubMed ID: 28577297
[TBL] [Abstract][Full Text] [Related]
3. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
4. HPV status and favourable outcome in vulvar squamous cancer.
Wakeham K; Kavanagh K; Cuschieri K; Millan D; Pollock KG; Bell S; Burton K; Reed NS; Graham SV
Int J Cancer; 2017 Mar; 140(5):1134-1146. PubMed ID: 27864932
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis.
Zhang J; Zhang Y; Zhang Z
PLoS One; 2018; 13(9):e0204162. PubMed ID: 30256833
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.
McAlpine JN; Leung SCY; Cheng A; Miller D; Talhouk A; Gilks CB; Karnezis AN
Histopathology; 2017 Aug; 71(2):238-246. PubMed ID: 28257152
[TBL] [Abstract][Full Text] [Related]
7. Vulvar cancer: Two pathways with different localization and prognosis.
Hinten F; Molijn A; Eckhardt L; Massuger LFAG; Quint W; Bult P; Bulten J; Melchers WJG; de Hullu JA
Gynecol Oncol; 2018 May; 149(2):310-317. PubMed ID: 29555332
[TBL] [Abstract][Full Text] [Related]
8. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis.
Sand FL; Nielsen DMB; Frederiksen MH; Rasmussen CL; Kjaer SK
Gynecol Oncol; 2019 Jan; 152(1):208-217. PubMed ID: 30415992
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance.
Ansink AC; Krul MR; De Weger RA; Kleyne JA; Pijpers H; Van Tinteren H; De Kraker EW; Helmerhorst TJ; Heintz AP
Gynecol Oncol; 1994 Feb; 52(2):180-4. PubMed ID: 8314136
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination.
Skapa P; Zamecnik J; Hamsikova E; Salakova M; Smahelova J; Jandova K; Robova H; Rob L; Tachezy R
Am J Surg Pathol; 2007 Dec; 31(12):1834-43. PubMed ID: 18043037
[TBL] [Abstract][Full Text] [Related]
13. Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node.
Lindell G; Näsman A; Jonsson C; Ehrsson RJ; Jacobsson H; Danielsson KG; Dalianis T; Källström BN; Larson B
Gynecol Oncol; 2010 May; 117(2):312-6. PubMed ID: 20138657
[TBL] [Abstract][Full Text] [Related]
14. Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma.
Eva LJ; Sadler L; Fong KL; Sahota S; Jones RW; Bigby SM
Gynecol Oncol; 2020 May; 157(2):450-455. PubMed ID: 32037194
[TBL] [Abstract][Full Text] [Related]
15. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
[TBL] [Abstract][Full Text] [Related]
16. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
Kashofer K; Regauer S
Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
[TBL] [Abstract][Full Text] [Related]
17. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
[TBL] [Abstract][Full Text] [Related]
18. Human papilloma virus, vulvar dystrophy, and vulvar carcinoma: differential expression of human papillomavirus and vulvar dystrophy in the presence and absence of squamous cell carcinoma of the vulva.
Sagerman PM; Choi YJ; Hu Y; Niedt GW
Gynecol Oncol; 1996 Jun; 61(3):328-32. PubMed ID: 8641610
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx.
Ritchie JM; Smith EM; Summersgill KF; Hoffman HT; Wang D; Klussmann JP; Turek LP; Haugen TH
Int J Cancer; 2003 Apr; 104(3):336-44. PubMed ID: 12569557
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: A review.
Nitecki R; Feltmate CM
Curr Probl Cancer; 2018 Sep; 42(5):476-485. PubMed ID: 30093165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
